Tomáš Szotkowski

454 total citations
36 papers, 137 citations indexed

About

Tomáš Szotkowski is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Tomáš Szotkowski has authored 36 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Tomáš Szotkowski's work include Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Tomáš Szotkowski is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Tomáš Szotkowski collaborates with scholars based in Czechia, Slovakia and Austria. Tomáš Szotkowski's co-authors include Karel Indrák, Peter Rohoň, Martin Čerňan, Tomáš Papajík, Luděk Raida, František Mrázek, Edgar Faber, Bohuslav Melichar, Hana Študentová and Petr Cetkovský and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Tomáš Szotkowski

32 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Szotkowski Czechia 7 94 42 32 28 27 36 137
Jennifer Kaivers Germany 7 132 1.4× 39 0.9× 42 1.3× 27 1.0× 28 1.0× 22 172
Diego V. Clé Brazil 9 79 0.8× 52 1.2× 53 1.7× 26 0.9× 13 0.5× 21 190
Isabel Cano Spain 8 80 0.9× 43 1.0× 43 1.3× 45 1.6× 15 0.6× 21 154
Feras Alfraih Saudi Arabia 8 63 0.7× 26 0.6× 40 1.3× 24 0.9× 24 0.9× 25 141
Giovangiacinto Paterno Italy 7 88 0.9× 35 0.8× 26 0.8× 29 1.0× 24 0.9× 25 128
Livia Giannoni Italy 8 75 0.8× 24 0.6× 20 0.6× 61 2.2× 19 0.7× 18 146
Tito Roccia United States 7 73 0.8× 47 1.1× 35 1.1× 49 1.8× 20 0.7× 25 150
Véronique Harrivel France 8 115 1.2× 39 0.9× 59 1.8× 34 1.2× 34 1.3× 17 170
Domenico Magro Italy 4 82 0.9× 37 0.9× 20 0.6× 18 0.6× 22 0.8× 5 109
Fumiaki Sano Japan 6 86 0.9× 77 1.8× 18 0.6× 21 0.8× 30 1.1× 26 153

Countries citing papers authored by Tomáš Szotkowski

Since Specialization
Citations

This map shows the geographic impact of Tomáš Szotkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Szotkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Szotkowski more than expected).

Fields of papers citing papers by Tomáš Szotkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Szotkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Szotkowski. The network helps show where Tomáš Szotkowski may publish in the future.

Co-authorship network of co-authors of Tomáš Szotkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Szotkowski. A scholar is included among the top collaborators of Tomáš Szotkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Szotkowski. Tomáš Szotkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weinbergerová, Barbora, Jiří Mayer, Wolfgang R. Sperr, et al.. (2024). Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British Journal of Haematology. 205(5). 1746–1750. 2 indexed citations
2.
Jindra, Pavel, Jan Vydra, Martin Čerňan, et al.. (2023). Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study. Annals of Hematology. 103(3). 981–992. 2 indexed citations
4.
Čerňan, Martin, Tomáš Szotkowski, Milan Kolář, et al.. (2022). Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site. Biomedical Papers. 167(3). 236–245. 1 indexed citations
5.
Minařík, Jiří, et al.. (2021). A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma. SHILAP Revista de lepidopterología. 9(8). e04570–e04570. 1 indexed citations
6.
Čerňan, Martin, Tomáš Szotkowski, Aleš Obr, et al.. (2021). COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic. Clinical Lymphoma Myeloma & Leukemia. 21(9). 606–612. 3 indexed citations
7.
Čerňan, Martin, Tomáš Szotkowski, Petr Cetkovský, et al.. (2020). Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. 67(3). 650–659. 3 indexed citations
8.
Jindra, Pavel, Luděk Raida, Michal Karas, et al.. (2019). Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome. Clinical Lymphoma Myeloma & Leukemia. 19(7). 462–469. 3 indexed citations
9.
Raida, Luděk, Tomáš Szotkowski, Peter Rohoň, et al.. (2018). Granulocyte transfusions collected after steroid priming for severe infections during neutropenia: A single center experience. Transfusion Clinique et Biologique. 26(4). 299–303.
10.
Kozubík, Kateřina Staňo, Lenka Radová, Kamila Réblová, et al.. (2018). C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies. International Journal of Hematology. 108(6). 652–657. 5 indexed citations
11.
Palová, Miroslava, et al.. (2018). Thrombin Generation Testing in Patients with Myelofibrosis. Clinical Laboratory. 64(09/2018). 1373–1383. 2 indexed citations
12.
Čerňan, Martin, et al.. (2017). Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment. Biomedical Papers. 161(3). 234–241. 8 indexed citations
14.
Szotkowski, Tomáš, Marie Jarošová, Olga Zimmermannová, et al.. (2015). Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene. Cancer Genetics. 208(12). 610–614.
15.
Szotkowski, Tomáš, et al.. (2013). Spontaneous splenic rupture in a patient with acute promyelocytic leukaemia during induction chemotherapy. Biomedical Papers. 159(2). 294–298. 3 indexed citations
17.
Szotkowski, Tomáš, et al.. (2010). Secondary acute myeloid leukemia – a single center experience. Neoplasma. 57(2). 170–178. 20 indexed citations
19.
20.
Szotkowski, Tomáš, et al.. (2007). SPONTANEOUS SPLENIC RUPTURE IN TWO PATIENTS WITH HEMATOLOGIC MALIGNANCY. Biomedical Papers. 151(1). 113–116. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026